FDA will consider Moderna's mRNA flu vaccine after all - Top-Institutions - MDSpire

FDA will consider Moderna's mRNA flu vaccine after all

  • By

  • Lauran Neergaard

  • February 18, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Allergy and Infectious Diseases (NIAID)
    National Institute of Allergy and Infectious Diseases (NIAID)

    Bethesda, MD

    Key Differentiators

    • Infectious Disease
    • Vaccine Research
    • Immunology

  • #2

    Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public Health

    Baltimore, MD

    Key Differentiators

    • Epidemiology
    • Vaccine Policy
    • Infectious Disease

  • #3

    Vaccine Research Center, National Institutes of Health (NIH)
    Vaccine Research Center, National Institutes of Health (NIH)

    Bethesda, MD

    Key Differentiators

    • Vaccine Development
    • Immunology
    • Clinical Trials

  • #4

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Immunology
    • Vaccine Research
    • Clinical Trials

  • #5

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Immunotherapy
    • Vaccine Research
    • Clinical Trials

Original Source(s)

FDA will consider Moderna's mRNA flu vaccine after all

  • by Lauran Neergaard

  • February 18, 2026

Related Content

NIH chief Bhattacharya to also temporarily run the embattled CDC

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

MHRA Approval for First UK-made mRNA Vaccine

Moderna receives MHRA approval for updated COVID-19 vaccine targeting SARS-CoV-2 variant LP.8.1

  • February 27, 2026

  • 2 min